Delisting riskPopularity #4,921
ELUT · NASDAQ · Biotechnology

Elutia (ELUT)

Develops drug-eluting biomatrices for surgical reconstruction and implanted-device complications.

$0.8102
After-hours close0.00 (0.00%)
At close$0.8102(−5.06%)